Actavis Laboratories, FL Ramipril Capsules, USP, 1.25 mg, 30-count bottle recall — FDA D-0118-2017
Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
Overview of recall records associated with Actavis Laboratories, FL, Inc., including dates, categories and classifications where available.
Classification mix: Class II: 4, Class III: 3.
Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
Failed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint.
Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.
Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell
Failed Tablet/Capsule Specifications: Presence of split or broken tablets.
Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.
Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.
This page summarizes recall records in which the official source identifies Actavis Laboratories, FL, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.